青光眼的健康和经济负担评估。
An assessment of the health and economic burdens of glaucoma.
机构信息
University of Southern California, Los Angeles, USA.
出版信息
Am J Ophthalmol. 2011 Oct;152(4):515-22. doi: 10.1016/j.ajo.2011.06.004.
Abstract
PURPOSE
To bring together information concerning the epidemiology and the economic and individual burdens of glaucoma.
DESIGN
Interpretive essay.
METHODS
Review and synthesis of selected literature published from 1991 through December 2010.
RESULTS
An estimated 3% of the global population over 40 years of age currently has glaucoma, the majority of whom are undiagnosed. Vision loss from glaucoma has a significant impact on health-related quality of life even in the early stages of disease. The overall burden increases as glaucomatous damage and vision loss progress. The economic burden of glaucoma is significant and increases as the disease worsens.
CONCLUSIONS
Early identification and treatment of patients with glaucoma and those with ocular hypertension at high risk of developing vision loss are likely to reduce an individual's loss of health-related quality of life as well as the personal and societal economic burdens.
摘要
目的
汇集青光眼的流行病学、经济和个人负担方面的信息。
设计
阐释性文章。
方法
对 1991 年至 2010 年 12 月期间发表的部分文献进行回顾和综合。
结果
目前全球约有 3%的 40 岁以上人群患有青光眼，其中大多数人未被诊断。即使在疾病早期，青光眼导致的视力丧失也会对健康相关生活质量产生重大影响。随着青光眼损害和视力丧失的进展，总体负担会增加。青光眼的经济负担是巨大的，且随着疾病的恶化而增加。
结论
早期发现青光眼患者和那些具有发生视力丧失高危风险的高眼压患者，可能会降低个人健康相关生活质量的损失以及个人和社会的经济负担。
相似文献
1
An assessment of the health and economic burdens of glaucoma.青光眼的健康和经济负担评估。
Am J Ophthalmol. 2011 Oct;152(4):515-22. doi: 10.1016/j.ajo.2011.06.004.
2
Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.眼压过高的管理：来自眼压过高治疗研究的成本效益方法。
Am J Ophthalmol. 2006 Jun;141(6):997-1008. doi: 10.1016/j.ajo.2006.01.019.
3
Routine eye examinations for persons 20-64 years of age: an evidence-based analysis.20至64岁人群的常规眼部检查：一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(15):1-81. Epub 2006 Jul 1.
4
Modelling the lifetime economic consequences of glaucoma in France.建模法国青光眼的终身经济后果。
J Med Econ. 2009 Mar;12(1):9-16. doi: 10.3111/13696990902728729.
5
A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.一项关于青光眼疾病严重程度相关资源利用和成本的多中心回顾性试点研究。
Arch Ophthalmol. 2006 Jan;124(1):12-9. doi: 10.1001/archopht.124.1.12.
6
The economic burden of vision loss and eye disorders among the United States population younger than 40 years.美国 40 岁以下人群中视力丧失和眼部疾病的经济负担。
Ophthalmology. 2013 Sep;120(9):1728-35. doi: 10.1016/j.ophtha.2013.01.068. Epub 2013 Apr 28.
7
[On the socio-economic relevance of glaucoma].[论青光眼的社会经济相关性]
Klin Monbl Augenheilkd. 2006 Oct;223(10):793-5. doi: 10.1055/s-2006-926689.
8
The economic burden of glaucoma and ocular hypertension: implications for patient management: a review.青光眼和高眼压症的经济负担：对患者管理的影响：综述
Drugs Aging. 2005;22(4):315-21. doi: 10.2165/00002512-200522040-00004.
9
Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.青光眼或高眼压症患者的资源利用与成本：基于荷兰回顾性病历审查的一年期研究。
J Glaucoma. 2001 Jun;10(3):184-91. doi: 10.1097/00061198-200106000-00007.
10
Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.眼压监测：证据综合与经济评估。
Health Technol Assess. 2012 Jun;16(29):1-271, iii-iv. doi: 10.3310/hta16290.
引用本文的文献
1
Prevalence, Incidence, and Treatment Characteristics of Primary Open-Angle Glaucoma Among Medicare Fee-for-Service Beneficiaries.医疗保险按服务收费受益人中原发性开角型青光眼的患病率、发病率及治疗特征
Clin Ophthalmol. 2025 Aug 28;19:3019-3031. doi: 10.2147/OPTH.S536664. eCollection 2025.
2
One-year outcomes of Bent ab-interno needle goniectomy with phacoemulsification in primary glaucoma.原发性青光眼行内切口弯针小梁切除术联合超声乳化白内障吸除术的1年疗效
Indian J Ophthalmol. 2025 Aug 1;73(8):1190-1195. doi: 10.4103/IJO.IJO_2622_24. Epub 2025 Jul 28.
3
Mechanobiology in the eye.眼部的力学生物学
NPJ Biol Phys Mech. 2025;2(1):18. doi: 10.1038/s44341-025-00022-6. Epub 2025 Jul 4.
4
"Optic nerve of steel": A case of very high intraocular pressures with markedly little visual field progression over years.“钢铁般的视神经”：一例眼内压极高但多年来视野进展明显极小的病例。
Am J Ophthalmol Case Rep. 2025 Apr 8;38:102325. doi: 10.1016/j.ajoc.2025.102325. eCollection 2025 Jun.
5
Biological Age Acceleration, Genetic Susceptibility, and Incident Glaucoma Risk.生物年龄加速、遗传易感性与青光眼发病风险
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):47. doi: 10.1167/iovs.66.4.47.
6
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma.大麻素作为治疗青光眼自身免疫性疾病的多靶点药物。
ACS Pharmacol Transl Sci. 2025 Mar 26;8(4):932-950. doi: 10.1021/acsptsci.4c00583. eCollection 2025 Apr 11.
7
Macular ganglion cell complex layer thickness measured with spectral-domain OCT in a large population-based cohort study.在一项基于大规模人群的队列研究中，用谱域光学相干断层扫描测量黄斑神经节细胞复合体层厚度。
BMC Ophthalmol. 2025 Apr 16;25(1):214. doi: 10.1186/s12886-025-03989-x.
8
Central Corneal Thickness and Its Association with the Severity of Primary Open-Angle Glaucoma.中央角膜厚度及其与原发性开角型青光眼严重程度的关联。
J West Afr Coll Surg. 2025 Apr-Jun;15(2):146-156. doi: 10.4103/jwas.jwas_1_24. Epub 2025 Feb 4.
9
Refining Glaucoma Management: Korean Population-Specific Findings from Visual Field and Optical Coherence Tomography Testing.优化青光眼管理：基于韩国人群视野和光学相干断层扫描测试的特定研究结果
Biomedicines. 2025 Jan 29;13(2):318. doi: 10.3390/biomedicines13020318.
10
Deep Learning Approach Predicts Longitudinal Retinal Nerve Fiber Layer Thickness Changes.深度学习方法可预测视网膜神经纤维层厚度的纵向变化。
Bioengineering (Basel). 2025 Jan 31;12(2):139. doi: 10.3390/bioengineering12020139.
本文引用的文献
1
The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.原发性开角型青光眼患者医疗服务成本增加：决策分析方法。
Am J Ophthalmol. 2010 Jul;150(1):74-81. doi: 10.1016/j.ajo.2010.01.037. Epub 2010 May 20.
2
The cost of visual impairment: purposes, perspectives, and guidance.视力损害的代价：目的、观点与指南
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1801-5. doi: 10.1167/iovs.09-4469. Epub 2010 Jan 13.
3
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.美国原发性开角型青光眼基于门诊的常规诊断及后续治疗的成本效益分析
Ophthalmology. 2009 May;116(5):823-32. doi: 10.1016/j.ophtha.2008.12.056. Epub 2009 Mar 14.
4
Risk factors for glaucoma onset and progression.青光眼发病和进展的危险因素。
Surv Ophthalmol. 2008 Nov;53 Suppl1:S3-10. doi: 10.1016/j.survophthal.2008.08.006.
5
Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15.青光眼患者的抑郁与生活质量：一项使用老年抑郁量表-15、视力相关功能评估及青光眼生活质量-15的横断面分析
J Glaucoma. 2008 Oct-Nov;17(7):546-51. doi: 10.1097/IJG.0b013e318163bdd1.
6
Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries.欧洲晚期原发性开角型青光眼：4个国家患者的社会和医疗保健维持成本及生活质量
Curr Med Res Opin. 2008 Jun;24(6):1763-70. doi: 10.1185/03007990802111068.
7
Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.1992年至2002年原发性开角型青光眼患者的青光眼药物使用率
Ophthalmology. 2008 Aug;115(8):1315-9, 1319.e1. doi: 10.1016/j.ophtha.2007.12.017. Epub 2008 Mar 5.
8
Cost-effectiveness of treating ocular hypertension.治疗高眼压症的成本效益
Ophthalmology. 2008 Jan;115(1):94-8. doi: 10.1016/j.ophtha.2007.01.040.
9
Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study.视野缺损对青光眼患者健康相关生活质量的影响：洛杉矶拉丁裔眼病研究
Ophthalmology. 2008 Jun;115(6):941-948.e1. doi: 10.1016/j.ophtha.2007.08.037. Epub 2007 Nov 12.
10
Glaucoma and mobility performance: the Salisbury Eye Evaluation Project.青光眼与行动能力表现：索尔兹伯里眼科评估项目
Ophthalmology. 2007 Dec;114(12):2232-7. doi: 10.1016/j.ophtha.2007.02.001. Epub 2007 Nov 5.
Zotero 插件